Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: As the world mobilizes to battle the virus, China, Hong Kong, Singapore and Taiwan have been relatively successful in curbing the spread so far. But a surge in imported cases in recent days has raised alarm that those efforts could rapidly unravel. "In many countries the number of confirmed cases can be described as explosive," Hong Kong leader Carrie Lam told a press briefing on Tuesday. "If we don't adopt some strict measures...I'm afraid all precaution efforts done in the past two months would be wasted." The latest tally from mainland China, the original epicenter of the coronavirus, showed 21 new confirmed cases on Monday, of which 20 involved infected travelers arriving from abroad, mostly Chinese nationals. Hong Kong said most of the recent confirmed cases in the past two weeks were imported. In Taiwan, 24 new cases up to Tuesday were all imported, while South Korea had 44 new infections involving infected travelers as of Sunday. Singapore confirmed 17 new infections on Monday, its biggest daily jump in cases, with 11 of those imported. The rush to flee virus hotspots in Europe and the United States has pushed up the price of flights. A ticket from London to Hong Kong was going for up to HK$50,000 on Monday night as people tried to get to the city before it imposed tougher restrictions. "It is safer home than in Britain as the policy to contain the outbreak under Boris Johnson is doubtful," said Ling, a Cambridge University student after landing in Hong Kong wearing a surgical mask and rubber gloves. The number of confirmed coronavirus cases in Britain rose to 1,543, up from 1,372 the day before, the health ministry said on Monday. The British death toll rose to 55. Four of Hong Kong's 157 confirmed coronavirus patients have died, while more than 3,200 people have died from the disease in mainland China, the highest number of fatalities. Measures in China, Hong Kong and Singapore, include city-wide lockdowns, border tightening, contact tracing efforts and strict social distancing. The virus has already taken a heavy economic toll, especially in mainland China and global financial hub Hong Kong, so any rise in new cases could be devastating. Hong Kong on Tuesday toughened measures on travelers, requiring 14 days of quarantine for those entering the city as of midnight on Thursday, and joined Singapore in advising against all non-essential travel. China said all inbound, non-transit travelers to Beijing need to be isolated for 14 days at designated quarantine venues, mostly hotels in the city. Macau, the world's biggest gambling hub, on Tuesday banned the entry of all non-residents, a move likely to have a significant impact on the already struggling casino industry. How seriously authorities in Asia take the virus battle has been underscored by punishments meted out or threatened to those who violate quarantine rules or give false information about their whereabouts or travel history. Taiwan said those who do not follow home isolation or quarantine rules could be fined between T$100,000 and T$1 million (US$ 3,300- US$33,000), and has advised people not to travel abroad at all. "We held firm to block the first wave of infection, but a new wave is coming, so everyone should cooperate with disease prevention efforts," Taiwanese Health Minister Chen Shih-chung told a news conference on Monday. While the imported infections in mainland China are still modest in number - 143 cases so far - authorities are concerned that virus carriers could trigger a second wave. The first imported case was reported in late February in the northwestern Ningxia region involving a traveler flying in from Iran. More cases quickly arrived from Iran, a hotspot with nearly 15,000 infections so far, followed by the first infected travelers from Italy in the first week of March. Soon, the infected were spotted on flights from countries including Spain, Britain, France, the Netherlands, Switzerland, the United States, Egypt, Saudi Arabia and the United Arab Emirates. The Philippines, Indonesia and Thailand entered the list this week.
[EX A]: Asia prepares for coronavirus boomerang wave as residents return home.

[EX Q]: "The article doesn't mention costs of angioplasty or costs of medications, which presumably must be taken for the rest of one's life. The article does mention that angioplasty is expensive, but does not provide real numbers or comparisons. The story provides absolute numbers of the primary endpoint over a 4-year period ""17 percent of those given angioplasty and drugs and nearly 16 percent of those given drugs alone had either died, suffered another heart attack or developed heart failure results considered to be statistically the same."" The story states that there was a worrisome trend toward more heart attacks in people who received late angioplasty compared to those who received just medications,although the story also tells readers that this could have been a statistical fluke or due to chance. However, other harms of the procedure were not discussed, including risks of the procedure itself, including bleeding, infection, or emotional distress/anxiety. The article also does not discuss risks of the alternative, e.g. medications, which have side effects, costs, or inconvenience. But, the story does discuss the main harm found in the study, e.g. a trend toward increased heart attacks. The research is important because it is a randomized controlled trial and the first such trial to be conducted for the clinical situation of late angioplasty in people with few to no symptoms after their heart attack. The story tells readers that enrollment of patients was delayed because ""doctors were unwilling to risk randomly assigning patients to drug treatment alone,"" indirectly stating that the study was a randomized trial. While an astute reader could probably pick up that this was a randomized trial, this fact could have been clearer. In addition, there islittlecontext around this being the first randomized trial for this clinical situation (as opposed to retrospective observational studies), although the story does tell readers that the results were surprising and that they could change guidelines. The story appropriately describes a heart attack, and more importantly, reinforces that early opening of the artery to restore blood flow to the heart after heart attack is still beneficial and that these results don't apply to that population or indeed the majority of people receiving angioplasties. No obvious disease mongering. The article provides an independent source of information from the chairman of theAmerican Heart Association program committee that reviewed the research. The story also provides information from the director of the National, Heart, Lung, and Blood Institute, but tells readers that this organization largely funded the research, therefore disclosing potential conflicts of interest. The story tells readers that the alternative that was tested in the latest research was medications, including those to lower blood pressure and cholesterol, aspirin, and anti-clotting drugs. The story could have mentioned beta-blockers specifically, since the protective effect of drug treatment may come from this family of drugs, although this is not yet proven. And the story could have been clearer about the course of treatment, e.g. that these medications are generally taken for the rest of one's life. The story tells readers that the usual treatment for people suffering a heart attackis angioplasty, even for a subset of people who weren't treated right away (the study population)/ The article also tells readers that the tendency to perform angioplasty electively (3 to 28 days after the event) was so strong, that recruitment to the study was prolonged in order to find enough patients (and their doctors) willing to participate in the study. It's widely understood that angioplasty and standard drug therapy after heart attackare not new. The article provides independent sources of information not included in the press release."
[EX A]: Study says late angioplasty futile

[EX Q]: A passenger waits for a delayed flight at Heathrow airport's terminal four in London August 12, 2006. REUTERS/Toby Melville The findings show that bariatric surgery, an increasingly popular operation, benefits patients' health and saves money, according to Pierre-Yves Cremieux of the economic consulting firm Analysis Group and the University of Quebec at Montreal, who led the study. Bariatric surgery alters the digestive system's anatomy, reducing the volume of food that can be eaten and digested. The most common form is gastric bypass, which makes the stomach smaller and permits food to bypass part of the small intestine. Some insurers have been reluctant to cover this surgery. "It demonstrates the fact that this is not cosmetic surgery," Cremieux said in a telephone interview. "The reason why you get your money back when you cover bariatric surgery is because the patients who were morbidly obese before and had high rates of diabetes and hypertension no longer do. They don't go to the doctor as much as they used to, and they don't go to the emergency room as much as they used to. Why? Because they are healthier," Cremieux added. How quickly an insurer recovered the costs of paying for bariatric surgery depended on the type performed, Cremieux reported in the American Journal of Managed Care. Insurers fully recovered the expense of covering minimally invasive bariatric surgery, which on average cost $17,000, within about two years, the study showed. They fully recovered the expense of more common bariatric procedures such as traditional gastric bypass surgery, which on average cost $26,000, within about four years. After surgery, the obese patients lost weight and incurred lower costs associated with prescription drugs, doctor visits and hospital services as they became healthier and less burdened by chronic disease, the researchers said. The researchers based the findings on insurance claims filed by 3,651 morbidly obese bariatric surgery patients and insurance claims filed by an equal number of morbidly obese people who did not have weight-loss surgery. It spanned six months of pre-surgical evaluation and care, the operation and up to five years of post-surgical care. Those who did not have surgery also were tracked for five years. The average age of the surgical patients was 44 and most were women. They began the study with obesity-related ailments like high blood pressure, diabetes and sleep apnea. Previous research has found that obese people who have weight-loss surgery are less likely to die from heart disease, diabetes and cancer than obese people who do not have such surgery. An estimated 205,000 people had bariatric surgery in the United States last year. The study was funded by Johnson & Johnson's Ethicon Endo-Surgery division, which makes instruments for bariatric surgery.
[EX A]:
Insurers recoup obesity surgery cost in 2-4 years.